<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">abd</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26734879</article-id>
      <article-id pub-id-type="pmc">4689086</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20153818</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Syndrome in Question</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Syndrome in question<xref ref-type="fn" rid="fn1">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Rebellato</surname>
            <given-names>Priscila Regina Orso</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rezende</surname>
            <given-names>Camila Makino</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Battaglin</surname>
            <given-names>Eveline Roesler</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Lima</surname>
            <given-names>Brunno Zeni</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fillus Neto</surname>
            <given-names>Jose</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <aff id="aff1"><label>1</label>Faculdade Evang&#xE9;lica do Paran&#xE1; (Fepar) - Curitiba (PR),
Brazil</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1">MAILING ADDRESS: Priscila Regina Orso Rebellato, Alameda
Augusto Stellfeld, 1908 Bigorrilho, 80730-150 - Curitiba - PR, Brazil.
E-mail: <email>prirebellato@yahoo.com.br</email></corresp>
        <fn fn-type="conflict">
          <p>Conflict of Interest: None</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Nov-Dec</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2015</year>
      </pub-date>
      <volume>90</volume>
      <issue>6</issue>
      <fpage>909</fpage>
      <lpage>911</lpage>
      <history>
        <date date-type="received">
          <day>05</day>
          <month>7</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>8</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2015 by Anais Brasileiros de
Dermatologia</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an Open Access article distributed under the terms of
the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Morbihan Syndrome is a rare entity with unknown etiology. It is clinically
characterized by chronic erythematous edema on the face - especially in the
middle and upper third of the face - and creates abnormal facial contours
that are initially intermitent but become permanent with the development of
the syndrome. The histopathology is nonspecific and its therapy is a major
challenge due to poor response to the various treatment options. We present
the case of a male patient with a five-month-history of disease.</p>
      </abstract>
      <kwd-group>
        <kwd>Edema</kwd>
        <kwd>Erythema</kwd>
        <kwd>Face</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>CASE REPORT</title>
      <p>A 38-year-old male patient presented with a periorbital indurated edema, which had
been progressively increasing for 5 months. The edema was painless, larger on
the upper eyelid, remained constant throughout the day and coincided with the
intermittent appearance of superimposed erythematous papules (<xref ref-type="fig" rid="f1">Figure 1</xref>). The patient denied itching and
had no eye or muscle symptoms. He had no previous skin diseases, comorbidities
or addictions, and an unremarkable family history. The patient was in good
general condition. There were neither changes in other organs nor systemic
symptoms.</p>
      <fig id="f1" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Periorbital edema, larger on the upper eyelid, with superimposed
erythematous papules (Figure 1).</p>
        </caption>
        <graphic xlink:href="abd-90-06-0909-g01"/>
      </fig>
      <p>Full blood count, renal function, VHS, proteinuria, FAN, anti-JO1, complement
dosages and orbit CT were within normality.</p>
      <p>Histopathology showed a preserved epidermis, chronic perivascular infiltration of
the papillary and middle dermis, dilated vessels and an increased number of mast
cells (<xref ref-type="fig" rid="f2">Figures 2</xref> and <xref ref-type="fig" rid="f3">3</xref>). These findings suggested the diagnosis of Morbihan
Syndrome.</p>
      <fig id="f2" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Intact basal layer. Superficial dermis with vessel ectasia, mild
fibrosis, edema and mild inflammatory infiltrate of mononuclear cells
(400x HE)</p>
        </caption>
        <graphic xlink:href="abd-90-06-0909-g02"/>
      </fig>
      <fig id="f3" orientation="portrait" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Evident increase in the number of mast cells and increased vascular
dilatation (100x Giemsa stain)</p>
        </caption>
        <graphic xlink:href="abd-90-06-0909-g03"/>
      </fig>
      <p>Treatment was initiated with minocycline and hydroxyzine. Nevertheless, as the
patient showed no improvement after 3 months, treatment was changed to
isotretinoin 20 mg/day for 6 months, combined with ketotifen 1 mg/day for the
first 2 months. At the end of this period, the patient showed good clinical
improvement with no local skin sequelae.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Morbihan syndrome is characterized by gradual erythema and solid edema mainly in
the upper two-thirds of the face. It may affect the forehead, glabella, eyelids,
nose and chin.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref></sup> It evolutes from initial intermittent
outbreaks that later become persistent and lead to a solid and permanent
infiltration of the skin, causing its bulking and altering the facies. Patients
usually report subjective symptoms due to the disfigurement of the facial
contour, which may affect them psychologically and cosmetically. It leaves the
patient in good general condition and there is no systemic
involvement.<sup><xref rid="r3" ref-type="bibr">3</xref></sup></p>
      <p>Its etiology is uncertain. It is assumed that triggering factors such as immune
contact urticaria would produce an increase in lymphatic load that would exceed
the drainage capacity of the lymph, leading to a persistent facial
swelling.<sup><xref rid="r3" ref-type="bibr">3</xref></sup> Other
explanations include chronic inflammation due to acne and ros&#xE1;cea causing
structural damage to blood and lymph vessels<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup>, and a
post-infectious inflammation cause by recurrent simple herpes
outbreaks.<sup><xref rid="r2" ref-type="bibr">2</xref></sup></p>
      <p>The histopathology is nonspecific.<sup><xref rid="r5" ref-type="bibr">5</xref></sup> A mild edema in the mid and deep dermis is found, along
with ectatic lymph vessels and la ymphohistiocytic perivascular and
perifollicular infiltrate.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r3" ref-type="bibr">3</xref></sup> An increased number of mast
cells<sup><xref rid="r3" ref-type="bibr">3</xref></sup> and
granulomas<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r5" ref-type="bibr">5</xref></sup> may be found. In the case of a
previous history of acne or ros&#xE1;cea, hyperplasia of sebaceous glands may be
observed.<sup><xref rid="r5" ref-type="bibr">5</xref></sup></p>
      <p>Laboratory and imaging tests are normal and do not help in the
diagnosis.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r5" ref-type="bibr">5</xref></sup></p>
      <p>The differential diagnoses include variants of the Melkersson-Rosenthal syndrome,
dermatomyositis, lupus erythematosus, lacrimal gland lymphoma, sarcoidosis,
chronic contact dermatitis, among others.<sup><xref rid="r3" ref-type="bibr">3</xref></sup> One could think of the blepharo-naso-facial syndrome
as another differential diagnosis. Nevertheless, this syndrome usually has its
onset at puberty, has a recurrent character and may lead to chronic changes in
eyelid support structures.</p>
      <p>Systemic steroids, radiation therapy, antibiotics, thalidomide and clofazimine
have already been used in the treatment of this syndrome, but have shown poor
response rates.<sup><xref rid="r3" ref-type="bibr">3</xref></sup> Isotretinoin
alone or in combination with ketotifen appears to be effective. More recent
studies state that its use at high doses and for a long period of time can lead
to good results.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r5" ref-type="bibr">5</xref></sup> Our patient improved after
treatment with isotretinoin combined with ketotifen, despite of the use at low
doses and for a short period of time. Facial lymphatic drainage can be used as a
supporting treatment<sup><xref rid="r4" ref-type="bibr">4</xref></sup>, and
contact with irritants or allergens that possibly trigger the disease should be
avoided.<sup><xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup></p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p>Financial Support: None</p>
      </fn>
      <fn fn-type="other">
        <p>How to cite this article: Rebellato PRO, Rezende CM, Battaglin ER, Lima BZ,
Fillus Neto J. Morbihan Syndrome. An Bras Dermatol. 2015; 90(6):909-11.</p>
      </fn>
      <fn id="fn1" fn-type="other">
        <label>*</label>
        <p>Study conducted at the Hospital Universit&#xE1;rio Evang&#xE9;lico de Curitiba -
Faculdade Evang&#xE9;lica do Paran&#xE1; (Huec-Fepar) - Curitiba (PR), Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>DE</given-names>
            </name>
          </person-group>
          <article-title>Successful long-term use of oral isotretinoin for the
management of Morbihan Disease</article-title>
          <source>Arch Dermatol</source>
          <year>2012</year>
          <volume>148</volume>
          <fpage>1395</fpage>
          <lpage>1398</lpage>
          <pub-id pub-id-type="pmid">23403940</pub-id>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Romiti</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Morbus Morbihan: solid and persistent facial edema and
erythema</article-title>
          <source>An Bras Dermatol</source>
          <year>2000</year>
          <volume>75</volume>
          <fpage>599</fpage>
          <lpage>603</lpage>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Franco</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Parra</surname>
              <given-names>IH</given-names>
            </name>
            <name>
              <surname>Bibiloni</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kowalczuk</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Galimberti</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Enfermidad de Morbihan</article-title>
          <source>Dermatol Argent</source>
          <year>2009</year>
          <volume>15</volume>
          <fpage>434</fpage>
          <lpage>436</lpage>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Estudillo</surname>
              <given-names>ZFB</given-names>
            </name>
            <name>
              <surname>G&#xF3;mez</surname>
              <given-names>MIR</given-names>
            </name>
            <name>
              <surname>Ibarra</surname>
              <given-names>MML</given-names>
            </name>
            <name>
              <surname>Ram&#xED;rez</surname>
              <given-names>MJQ</given-names>
            </name>
          </person-group>
          <article-title>Edema s&#xF3;lido facial persistente relacionado com acne
(Morbihan)</article-title>
          <source>Dermatol Rev Mex</source>
          <year>2012</year>
          <volume>56</volume>
          <fpage>341</fpage>
          <lpage>345</lpage>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Veraldi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Persico</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Francia</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Morbihan Syndrome</article-title>
          <source>Indian Dermatol Online J</source>
          <year>2013</year>
          <volume>4</volume>
          <fpage>122</fpage>
          <lpage>124</lpage>
          <pub-id pub-id-type="pmid">23741671</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
